Summary
In the pathogenesis of cervical carcinoma there are three major components, two of them related to the role of human papillomaviruses (HPV). First, the effect of viral E6 and E7 proteins. Second, the integration of viral DNA in chromosomal regions associated with well known tumour phenotypes. Some of these viral integrations occur recurrently at specific chromosomal locations, such as 8q24 and 12q15, both harbouring HPV18 and HPV16. And third, there are other recurrent genetic alterations not linked to HPV. Recurrent losses of heterozygosity (LOH) have been detected in chromosome regions 3p14–22, 4p16, 5p15, 6p21–22, 11q23, 17p13.3 without effect on p53, 18q12–22 and 19q13, all of them suggesting the alteration of putative tumour suppressor genes not yet identified. Recurrent amplification has been mapped to 3q+ arm, with the common region in 3q24–28 in 90% of invasive carcinomas. The mutator phenotype, microsatellite instability, plays a minor role and is detected in only 7% of cervical carcinomas. The development of cervical carcinoma requires the sequential occurrence and selection of several genetic alterations. The identification of the specific genes involved, and their correlation with specific tumour properties and stages could improve the understanding and perhaps the management of cervical carcinoma.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Antinore, M. J., Birrer, M. J., Patel, D., Nader, L. & McCance, D. J. (1996). The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factor. EMBO J 15: 1950–1960.
Atkin, N. B., Baker, M. C. & Fox, M. F. (1989). Chromosome changes in 43 carcinomas of the cervix uteri. Cancer Genet Cytogenet 44: 229–241.
Banks, L., Edmonds, C. & Vousden, K. H. (1995). Ability of the HPV16 E7 protein to bind Rb and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells. Oncogene 5: 1383–1389.
Bartholomew, I. S., Glenville, S., Sarkar, S., Burt, D. J., Stanley, M. A., Ruiz-Cabello, F., Chengang, J., Garrido, F. & Stern, P. L. (1997). Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I antigens by steroid hormones in cervical tumor cells. Cancer Res 57: 937–942.
Bartsch, D., Boye, B., Baust, C., zur Hausen, H. & Schwarz, E. (1992). Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J 11: 2283–2291.
Bauer-Hoffman, R., Borghouts, C., Bourda, E., F, R. s. & Alonso, A. (1996). Genomic cloning and characterization of the nonoccupied allele corresponding to the integration site of human papillomavirus type 16 DNA in the cervical cancer cell line SiHa. Virology 217: 33–41.
Bethwaite, P. B., Koreh, J., Herrington, C. S. & McGee, J. O. (1995). Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23. Br J Cancer 71: 814–818.
Bosch, F. X., Manos, M. M., Muñoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R. & Shah, K. V. (1995). Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87: 796–802.
Braly, P. (1996). Preventing cervical cancer. Nat Med 2: 749–751.
Cannistra, S. A. & Niloff, J. (1996). Cancer of the uterine cervix. N Engl J Med 334: 1030–1038.
Castren, K., Vahakangas, K., Heikkinen, E. & Ranki, A. (1998). Absence of p53 mutations in benign and pre-malignant male genital lesions with over-expressed p53 protein. Int J Cancer 77: 674–678.
Couturier, J., Sastre-Garau, X., Schneider-Maunoury, S., Labib, A. & Orth, G. (1991). Integration of papillomavirus DNA near MYC genes in genital carcinomas and its consequences for proto-oncogene expression. J Virol 65: 4534–4538.
Cullen, A. P., Reid, R., Campion, M. & Campion, A. T. Lr (1991). Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasia. J Virol 65: 606–612.
Chen, T., Pecoraro, G. & Defendi, V. (1993). Genetic analysis of in vitro progression of human papillomavirus transfected human cervical cells. Cancer Res 53: 1167–1171.
Choo, K., Lee, H., Chong, K. & Chou, H. (1990). Analysis of the unoccupied site of an integrated human papilomavirus 16 sequence in a cervical carcinoma. Virology 178: 621–625.
Choo, K., Huang, C., Chen, C. M., Han, C. P. & Au, L. C. (1995). Jun-B oncogene aberrations in cervical cancer cell lines. Cancer Lett 93: 249–253.
Chu, T-Y, Shen, C-Y, Chiou, Y-S, Perng, C-L, Yu, M-S & Liu, H-S (1998). HPV-associated cervical cancers show frequent allelic loss at 3p14 but no apparent aberration of FHIT mRNA. Int J Cancer 75: 199–204.
Dokianakis, D. N., Sourvinos, G., Sakkas, S., Athanasiadou, E. & Spandidos, D. A. (1998). Detection of HPV and ras gene mutations in cervical smears from female genital lesions. Oncol Rep 5: 1195–1198.
Dowhanick, J. J., McBride, A. A. & Howley, P. M. (1995). Suppression of cellular proliferation by the papillomavirus E2 protein. J Virol 69: 7791–7799.
Durst, M., Croce, C., Gissman, L., Schwarz, E. & Huebner, K. (1987). Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proc Natl Acad Sci USA 84: 1070–1074.
El Awady, M., Kaplan, J. B. & Burk, R. D., SJ, OB (1987). Molecular analysis of integrated human papillomavirus 16 sequences in the cervical cancer cell line SiHa. Virology 159: 389–398.
Frattini, M. G., Hurst, S. D., Lim, H. B., Swaminathan, S. & Laimins, L. A. (1997). Abrogation of a mitotic checkpoint by E2 proteins from oncogenic human papillomaviruses correlates with increased turnover of the p53 tumor suppressor protein. Embo J 16: 318–331.
Fujita, M., Inoue, M., Tanizawa, O., Iwamoto, S. & Enomoto, T. (1992). Alterations of p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. Cancer Res 52: 5323–5328.
Gallego, M. I. & Lazo, P. A. (1995). Deletion in human chromosome region 12q13–15 by integration of human papillomavirus DNA in a cervical carcinoma cell line. J Biol Chem 270: 24321–24326.
Gallego, M. I., Shoenmakers, EPFM, Van de Ven, W. J. M. & Lazo, P. A. (1997). Complex genomic rearrangement within the 12q15 multiple aberration region induced by integrated human papillomavirus 18 in a cervical carcinoma cell line. Mol Carcinogen 19: 114–121.
Gloss, B., Chong, T. & Bernard, H. (1989). Numerous nuclear proteins bind the long control region of human papillomavirus type 16: a subset of 6 of 23 DNaseI-protected segments coincides with the location of the cell-type-specific enhancer. J Virol 63: 1142–1152.
Greeblatt, M. S., Bennet, W. P., Hollstein, M. & Harris, C. C. (1994). Mutations in the p53 tumor suppressor genes: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855–4878.
Greenspan, D. L., Connolly, D. C., Wu, R., Lei, R. Y., Vogelstein, J. T. C., Kim, Y., Mok, J. E., Muñoz, N., Bosch, F. X., Shah, K. & Cho, K. R. (1997). Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Cancer Res 57: 4692–4698.
Hampton, G. M., Larson, A. A., Baergen, R. N., Sommers, R. L., Kren, S. & Cavanee, W. K. (1996). Simultaneous assessment of loss of heterozygosity at multiple microsatellite loci using semi-automated fluorescence based detection: subregional mapping of chromosome 4 in cervical carcinoma. Proc Natl Acad Sci USA 93: 6704–6709.
Hampton, G. M., Penny, L. A., Baergen, R. N., Larson, A., Brewer, C., Liao, S., Busby-Earle, R. M. C., Williams, A. W. R., Steel, C. M., Bird, C. C., Stanbridge, E. J. & Evans, G. A. (1994). Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22–q24. Proc Natl Acad Sci USA 91: 6953–6957.
Hayashi, S., Tanimoto, K., Hajiro-Nakanishi, K., Kurosomi, M., Higashi, Y., Imai, K., Suga, K. & Nakachi, K. (1997). Abnormal FHIT transcript in human breast carcinomas: a clinicopathological and epidemiological analysis of 61 Japanese cases. Cancer Res 57: 1981–1985.
Helland, A., Borresen-Dale, A., Peltomaki, P., Kristensen, M., Nesland, J. M., De La Chapelle, A. & Lothe, R. A. (1997). Microsatellite instability in cervical and endometrial carcinomas. Int J Cancer 70: 499–501.
Helland, A., Karlsen, F., Due, E. U., Holm, R., Kristensen, G. & Borresen-Dale, A. (1998a). Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load. Br J Cancer 78: 69–72.
Helland, A., Olsen, A. O., Gjoen, K., Akselsen, H. E., Sauer, T., Magnus, P., Borresen-Dale, A. L. & Ronningen, K. S. (1998b). An increased risk of cervical intra-epithelial neoplasia grade II-III among human papillomavirus positive patients with the HLA-DQA1*0102–DQB1*0602 haplotype: a population-based case-control study of Norwegian women. Int J Cancer 76: 19–24.
Heselmeyer, K., Schröck, E., Du Manoir, S., Blegen, H., Shah, K. V., Steinbeck, R., Auer, G. & Ried, T. (1996). Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix. Proc Natl Acad Sci USA 93: 479–484.
Heselmeyer, K., Macville, M., Schrock, E., Blegen, H., Hellstrom, A-C, Shah, K., Auer, G. & Ried, T. (1997). Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Genes Chromosom Cancer 19: 233–240.
Howley, P. M. (1995). Papillomavirinae: The viruses and their replication. In Virology, Fields BN, Knipe DM and Howley PM (eds), Vol 2. pp. 2045–2076. Lippincot-Raven: Philadelphia
Hueber, A., Zornig, M., Lyon, D., Suda, T., Nagata, S. & Evan, G. I. (1997). Requirement for the Cd95 receptor-ligand pathway in c-myc-induced apoptosis. Science 278: 1305–1309.
Huettner, P. C., Gerhard, D. S., Li, L., Gersell, D. J., Dunnigan, K., Kamarasova, T. & Rader, J. S. (1998). Loss of heterozygosity in clinical stage IB cervical carcinoma: relationship with clinical and histopathologic features. Hum Pathol 29: 364–370.
Iglesias, M., Yen, K., Gaiotti, D., Hildesheim, A., Stoler, M. H. & Woodsworth, C. D. (1998). Human papillomavirus type 16 E7 protein sensitizes cervical keratinocytes to apoptosis and release of interleukin 1a. Oncogene 17: 1195–1205.
Jeon, S. & Lambert, P. (1995). Integration of human papillomavirus type 16 DNA in the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci USA 92: 1654–1658.
Jeon, S., Allen-Hoffmann, B. L. & Lambert, P. F. (1995). Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 69: 2989–2997.
Jones, M. H. & Nakamura, Y. (1992). Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphisms. Oncogene 7: 1631–1634.
Kaelbing, M., Burk, R. D., Atkin, N. B., Johnson, A. B. & Klinger, H. P. (1992). Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomas. Lancet 340: 140–142.
Kalantari, M., Karlsen, F., Kristensen, G., Holm, R., Hagmar, B. & Johansson, B. (1998). Disruption of the E1 and E2 reading frames of HPV16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol 17: 146–153.
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G. & Sherr, C. J. (1997). Tumor suppression at the INK4a locus mediated by the alternative reading frame product p19arf. Cell 91: 649–659.
Karlsen, F., Rabbitts, P. H., Sundresan, V. & Hagmar, B. (1994). PCR-RFLP studies on chromosome 3p in formaldehyde-fixed paraffin-embedded cervical cancer tissues. Int J Cancer 58: 787–792.
Kersemaekers, A. M., Hermans, J., Fleuren, G. J. & van de Vijver, M. J. (1998a). Loss of heterozygosity for defined regions on chromosomes 3, 11 and 17 in carcinomas of the uterine cervix. Br J Cancer 77: 192–200.
Kersemaekers, A. M., Kenter, G. G., Hermans, J., Fleuren, G. J. & van de Vijver, M. J. (1998b). Allelic loss and prognosis in carcinoma of the uterine cervix [In Process Citation]. Int J Cancer 79: 411–417.
Kim, J. W., Namkoong, S. E., Ryu, S. W., Kim, H. S., Shin, J. W., Lee, J. M., Kim, D. H. & Kim, I. K. (1998). Absence of p15INK4B and p16INK4A gene alterations in primary cervical carcinoma tissues and cell lines with human papillomavirus infection [In Process Citation]. Gynecol Oncol 70: 75–79.
Kinzler, K. W. & Vogelstein, B. (1996). Lessons from hereditary colorectal cancer. Cell 87: 159–170.
Kinzler, K. W. & Vogelstein, B. (1998). Landscaping the cancer terrain. Science 280: 1036–1037.
Kirchhoff, M., Rose, H., Petersen, B. L., Maahr, J., Gerdes, T., Lundsteen, C., Bryndorf, T., Kryger-Baggesen, N., Christensen, L., Engelholm, S. A. & Philip, J. (1999). Comparative genomic hybridization reveals a recurrence pattern of chromosomal aberrations in severe dysplasia/carcinoma in situ of the cervix and in advanced-stage cervical carcinoma. Genes Chrom Cancer 24: 144–150.
Kohno, T., Takayama, H., Hamaguchi, M., Takano, H., Yamaguchi, N., Tsuda, H., Hirohashi, S., Vissing, H., Shimizu, M., Oshimura, M. & Yokota, J. (1993). Deletion mapping of chromosome 3p in human uterine cervical cancer. Oncogene 8: 1825–1832.
Koi, M., Morita, H., Yamada, H., Satoh, H., Barrett, J. C. & Oshimura, M. (1989). Normal human chromosome 11 suppresses tumorigenicity of human cervical tumor cell line SiHa. Mol Carcinog 2: 12–21.
Konishi, H., Takahashi, T., Kozaki, K., Yatabe, Y., Mitsudomi, T., Fujii, Y., Sugiura, T. & Matsuda, H. (1998). Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers. Oncogene 17: 2095–2100.
Krammer, P. H. (1997). The tumor strikes back: new data on expression of CD95 (APO-1/FAS) receptor/ligand system may cause paradigm changes in our view on drug treatment and tumor immunology. Cell Death Diff 4: 362–364.
Ku, J-L, Kim, W-H, Park, H-S, Kang, S-B & Park, J-G (1977). Establishment and characterization of 12 uterine cervical carcinoma cell lines: common sequence variation in the E7 gene of HPV-16 positive cell lines. Int J Cancer 72: 313–320.
Ku, W-H, Liu, I-L, Yen, M-S, Chien, C. C., Yue, C-T, Ma, Y., Chang, S., Ng, H., Wu, C. & Shen, C. (1997). Genomic deletion and p53 inactivation in cervical carcinoma. Int J Cancer 72: 270–276.
Kubbutat, M. H. G. & Vousden, K. H. (1996). Role of E6 and E7 oncoproteins in HPV-induced anogenital malignancies. Semin Virol 7: 295–304.
Kurvinen, K., Syrjänen, K. & Syrjänen, S. (1996). p53 and bcl-2 proteins as prognostic markers in human papillomavirus-associated cervical lesions. J Clin Onc 14: 2120–2130.
Larson, A. A., Kern, S., Sommers, R. L., Yokota, J., Cavenee, W. K. & Hampton, G. M. (1996). Analysis of replication error phenotypes in cervical carcinoma. Cancer Res 56: 1426–1431.
Larson, A. A., Kern, S., Curtiss, S., Gordon, R., Cavanee, W. K. & Hampton, G. M. (1997). High resolution analysis of chromosome 3p alterations in cervical cancer. Cancer Res 57: 4082–4090.
Lazo, P. A. (1988a). Human papillomaviruses in oncogenesis. BioEssays 9: 158–162.
Lazo, P. A. (1988b). Rearrangement of both alleles of human chromosome 8 in HeLa cells, one of them as a result of papillomavirus DNA integration. J Biol Chem 263: 360–367.
Lazo, P. A., Gallego, M. I., Ballester, S. & Feduchi, E. (1992). Genetic alterations by human papillomaviruses in oncogenesis. FEBS Lett 300: 109–113.
Le Beau, M. M., Drabkin, H., Glover, T. W., Gemmill, R., Rassool, F. V., McKeithan, T. W. & Smith, D. I. (1998). An FHIT tumor suppressor gene? Genes Chromosom Cancer 21: 281–289.
Leis, P. F., Stevens, K. R., Baer, S. C., Kadmon, D., Goldberg, L. H. & Wang, X. J. (1998). A c-rasHa mutation in the metastasis of a human papillomavirus (HPV)-18 positive penile squamous cell carcinoma suggests a cooperative effect between HPV-18 and c-rasHa activation in malignant progression. Cancer 83: 122–129.
Lengauer, C., Kinzler, K. W. & Vogelstein, B. (1998). Genetic instabilities in human cancers. Nature 396: 643–649.
Lopez-Borges, S., Gallego, M. I. & Lazo, P. A. (1998). Recurrent integration of papillomavirus DNA within the human 12q14–15 uterine breakpoint region in genital carcinomas [In Process Citation]. Genes Chromosomes Cancer 23: 55–60.
Mao, L., Fan, Y-H, Lotan, R. & Hong, W. K. (1996). Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Cancer Res 56: 5128–5131.
Mitelman, F., Mertens, F. & Johansson, B. (1997). A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15: 417–474.
Mitra, A. B., Murty, V., Li, R. G., Pratap, M., Luthra, U. K. & Chaganti, R. S. K. (1994a). Allelotype analysis of cervical carcinoma. Cancer Res 54: 4481–4487.
Mitra, A. B., Murty, V., Pratap, M., Dodhani, P. & Chaganti, R. S. K. (1994b). ERBB2 (HER2/neu) oncogene is frequently amplified in squamous carcinoma of the uterine cervix. Cancer Res 54: 637–639.
Montgomery, K., Tedford, K. L. & McDougall, J. K. (1995). Genetic instability of chromosome 3 in HPV immortalized and tumorigenic human keratinocytes. Genes Chrom Cancer 14: 97–105.
Muller, C. Y., O’Boyle, J. D., Fong, K. M., Wistuba, I. I., Biesterveld, E., Ahmadian, M., Miller, D. S., Gazdar, A. F. & Minna, J. D. (1998). Abnormalities of fragile histidine triad genomic and complementary DNA in cervical cancer: association with human papillomavirus type. J Natl Cancer Inst 90: 433–439.
Mullokandov, M. R., Kholodilov, N. G., Atkin, N. B., Burk, R. D., Johnson, A. B. & Klinger, H. P. (1996). Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papillomavirus tumor status. Cancer Res 56: 197–205.
Ning, Y., Weber, J. L., Killary, A. M., Ledbetter, D. H., Smith, J. R. & Pereira-Smith, O. M. (1991). Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. Proc Natl Acad Sci USA 88: 5635–5639.
O’Connor, M. J., Tan, S., Tan, C. & Bernard, H. (1996). YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J Virol 70: 6529–6539.
Oshimura, M., Kugoh, H., Koi, M., Shimizu, M., Yamada, H., Satoh, H. & Barrett, J. C. (1990). Transfer of a normal human chromosome 11 suppresses tumorigenicity of some but not all tumor cell lines. J Cell Biochem 42: 135–142.
Park, S., Kang, Y., Kim, B., Lee, S., Lee, E., Lee, K., Park, K. & Lee, J. (1995). Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas. Cancer Genet Cytogenet 79: 74–78.
Pinion, S. B., Kennedy, J. H., Miller, R. W. & MacLean, A. B. (1991). Oncogene expression in cervical intraepithelial neoplasia and invasive cancer of the cervix. Lancet 337: 819–820.
Pirisi, L., Yasumoto, S., Feller, M., Doniger, J. & DiPaolo, J. A. (1987). Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol 61: 1061–1066.
Popescu, N. C. & DiPaolo, J. A. (1989). Preferential sites for viral integration on mammalian genome. Cancer Genet Cytogenet 42: 157–171.
Popescu, N. C., DiPaolo, J. A. & Amsbaugh, S. C. (1987). Integration sites of human papillomavirus 18 DNA sequences on HeLa cell chromosomes. Cytogenet Cell Genet 44: 58–62.
Popescu, N. C., Zimonjic, D. & DiPaolo, J. A. (1990). Viral integration, fragile sites and proto-oncogenes in human neoplasia. Hum Genet 44: 58–62.
Rabbitts, T. H. (1994). Chromosomal translocations in human cancer. Nature 372: 143–149.
Rabbitts, T. H. (1997). Chromosomal breakpoints hit the spot. Nat Med 3: 496–497.
Rosl, F., Achtstatter, T., Bauknecht, T., Hutter, K. J., Futterman, G. & zur Hausen, H. (1991). Extinction of the HPV18 upstream regulatory region in cervical carcinoma cells after fusion with non-tumorigenic human keratinocytes under non-selective conditions. EMBO J 10: 1337–1345.
Sánchez-García, I. (1997). Consequences of chromosomal abnormalities in tumor development. Annu Rev Genet 31: 429–453.
Sastre-Garau, X., Couturier, J., Favre, M. & Orth, G. (1995). A recurrent human papillomavirus integration site at chromosome region 12q14–15 in SW756 and SK-v cell lines derived from genital tumors. CR Acad Sci III 318: 475–478.
Saxon, P. J., Srivatsan, E. S. & Stanbridge, E. J. (1986). Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells. Embo J 5: 3461–3466.
Schneider, J. F., McGlennen, R. C., LaBresh, K. V., Ostrow, R. S. & Faras, A. J. (1991). Rhesus papillomavirus type 1 cooperates with activated ras in transforming primary epithelial rat cells independent of dexamethasone. J Virol 65: 3354–3358.
Shah, K. V. & Howley, P. M. (1995). Papillomaviruses. In Virology 2: Fields BN, Knipe DM, Howley PN Lippincot-Raven: Philadelphia 2077–2109.
Smith, P. P., Friedman, C. L., Bryant, E. M. & McDougall, J. K. (1992). Viral integration and fragile sites in human papillomavirus immortalized human keratinocyte cell lines. Genes Chromosomes Cancer 5: 150–157.
Southern, S. A. & Herrington, C. S. (1997). Interphase karyotypic analysis of chromosomes 11, 17 and X in invasive squamous-cell carcinoma pf the cervix: Morphological correlation with HPV infection. Int J Cancer 70: 502–507.
Sozzi, G., Veronese, M. L., Negrini, M., Baffa, R., Cotticelli, M. G., Inoue, H., Pilotti, S., De Gregorio, L., Pastorino, U., Pierotti, M. A., Ohta, M., Huebner, K., Croce, C. M. & Tornielli, S. (1996). The FHIT gene at 3p14.2 is abnormal in lung cancer. Cell 85: 17–26.
Srivasan, E. S., Misra, B. C., Venugopalan, M. & Wilczynski, S. P. (1991). Loss of heterozygosity for alleles on chromosome 11 in cervical carcinoma. Am J Hum Genet 49: 868–877.
Steenbergen, R. D. M., Hermsen, M., Walboomers, J. M. M., Joenje, H., Arwert, F., Meijer, C. & Snijders, P. J. F. (1995). Integrated human papillomavirus type 16 and loss of heterozygosity at 11q22 and 18q21 in an oral carcinoma and its derivative cell line. Cancer Res 55: 5465–5471.
Steenbergen, R. D. M., Walboomers, J. M. M., Meijer, C., van der Raaij-Helmer, E. M. H., Parker, J. N., Chow, L. T., Broker, T. R. & Snijders, P. J. F. (1996). Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele loss at 3p, 10p, 11q and/or 18q. Oncogene 13: 1249–1257.
Stoppler, H., Stoppler, M. C., Johnson, E., Simbulan-Rosenthal, C. M., Smulson, M. E., lyer, S., Rosenthal, D. S. & Schlegel, R. (1998). The E7 protein of human papillomavirus type 16 sensitizes primary human keratinocytes to apoptosis. Oncogene 17: 1207–1214.
Thiagalingam, S., Lisistsyn, N. A., Hamaguchi, M., Wigler, M. H., Willson, J. K. V., Markowitz, S. D., Leach, F. S., Kinzler, K. W. & Vogelstein, B. (1996). Evaluation of the FHIT gene in colorectal cancers. Cancer Res 56: 2936–2939.
Thomas, M., Matlashewski, G., Pim, D. & Banks, L. (1996). Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV18 E6 through ubiquitin mediated degradation. Oncogene 13: 265–273.
Tomlinson, I. & Bodmer, W. (1999). Selection, the mutation rate and cancer: ensuring that the tail does not wag the tail. Nat Med 5: 11–12.
Tomlinson, I. P. M., Novelli, M. R. & Bodmer, W. F. (1996). The mutation rate and cancer. Proc Natl Acad Sci USA 93: 14800–14803.
Uejima, H., Mitsuya, K., Kugoh, H., Horikawa, I. & Oshimura, M. (1995). Normal human chromosome 2 induces cellular senescence in the human cervical carcinoma cell line SiHa. Genes Chromosomes Cancer 14: 120–127.
Unger, E. R., Vernon, S. D., Thoms, W. W., Nisenbaum, R., Spann, C. O., Horowitz, I. R., Icenogle, J. P. & Reeves, W. C. (1995). Human papillomavirus and disease-free survival in FIGO stage Ib cervical cancer. J Infect Dis 172: 1184–1190.
Vernon, S. D., Unger, E. R., Miller, D. L., Lee, D. R. & Reeves, W. C. (1997). Association of human papillomavirus type 16 integration in the E2 gene with poor disease-free survival from cervical cancer. Int J Cancer 74: 50–56.
Werness, B. A., Levine, A. J. & Howley, P. M. (1990). Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248: 76–79.
Wilke, C. M., Hall, B. K., Hoge, A., Paradee, W., Smith, D. I. & Glover, T. W. (1996). FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Hum Mol Genet 5: 187–195.
Yokota, J., Tsukada, Y., Nakajima, T., Gotoh, M., Shimosato, Y., Mori, N., Tsunokawa, Y., Sugimura, T. & Terada, M. (1989). Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res 49: 3598–3601.
Yoshino, K., Enomoto, T., Nakamura, T., Nakashima, R., Wada, H., Saitoh, J., Noda, K. & Murata, Y. (1998). Aberrant FHIT transcripts in squamous cell carcinoma of the uterine cervix. Int J Cancer 76: 176–181.
Zimonjic, D. B., Popescu, N. C. & DiPaolo, J. A. (1994). Chromosomal organization of viral integration sites in human papillomavirus-immortalized human keratynocytes cell lines. Cancer Genet Cytogenet 72: 39–43.
Zimonjic, D. B., Druck, T., Ohta, M., Kastury, K., Coce, C. M., Popescu, N. & Huebner, K. (1997). Position of chromosome 3p14.2 fragile site (FRA3B) within the FHIT gene. Cancer Res 57: 1166–1170.
Zou, T. T., Lei, J., Shi, Y. Q., Wang, S., Souza, R. F., Kong, D., Shimada, Y., Smolinski, K. N., Greenwald, B. D., Abraham, J. M., Harpaz, N. & Meltzer, S. J. (1997). FHIT alterations in esophageal cancer and ulcerative colitis (UC). Oncogene 15: 101–105.
zur Hausen, H. (1994). Human papillomaviruses. Annu Rev Microbiol 48: 427–447.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Lazo, P. The molecular genetics of cervical carcinoma. Br J Cancer 80, 2008–2018 (1999). https://doi.org/10.1038/sj.bjc.6690635
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690635
Keywords
This article is cited by
-
A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth
Scientific Reports (2019)
-
IGF2 is Deregulated During the Development of Uterine Cervical Carcinoma in Indian Patients
Biochemical Genetics (2019)
-
Microsatellite instability in prostate cancer by PCR or next-generation sequencing
Journal for ImmunoTherapy of Cancer (2018)
-
Assessment of the frequency of genetic alterations (LOH/MSI) in patients with intraepithelial cervical lesions with HPV infection: a pilot study
Medical Oncology (2016)
-
HPV typing and its relation with apoptosis in cervical carcinoma from Indian population
Tumor Biology (2012)